1. Home
  2. SNGX vs MRIN Comparison

SNGX vs MRIN Comparison

Compare SNGX & MRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • MRIN
  • Stock Information
  • Founded
  • SNGX 1987
  • MRIN 2006
  • Country
  • SNGX United States
  • MRIN United States
  • Employees
  • SNGX N/A
  • MRIN N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • MRIN EDP Services
  • Sector
  • SNGX Health Care
  • MRIN Technology
  • Exchange
  • SNGX Nasdaq
  • MRIN Nasdaq
  • Market Cap
  • SNGX 7.4M
  • MRIN 6.7M
  • IPO Year
  • SNGX 1987
  • MRIN 2013
  • Fundamental
  • Price
  • SNGX $2.32
  • MRIN $2.09
  • Analyst Decision
  • SNGX
  • MRIN
  • Analyst Count
  • SNGX 0
  • MRIN 0
  • Target Price
  • SNGX N/A
  • MRIN N/A
  • AVG Volume (30 Days)
  • SNGX 620.7K
  • MRIN 16.8K
  • Earning Date
  • SNGX 03-14-2025
  • MRIN 02-20-2025
  • Dividend Yield
  • SNGX N/A
  • MRIN N/A
  • EPS Growth
  • SNGX N/A
  • MRIN N/A
  • EPS
  • SNGX N/A
  • MRIN N/A
  • Revenue
  • SNGX $364,183.00
  • MRIN $16,707,999.00
  • Revenue This Year
  • SNGX N/A
  • MRIN N/A
  • Revenue Next Year
  • SNGX $76.64
  • MRIN N/A
  • P/E Ratio
  • SNGX N/A
  • MRIN N/A
  • Revenue Growth
  • SNGX N/A
  • MRIN N/A
  • 52 Week Low
  • SNGX $0.32
  • MRIN $1.44
  • 52 Week High
  • SNGX $14.83
  • MRIN $5.46
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 36.12
  • MRIN 51.22
  • Support Level
  • SNGX $2.23
  • MRIN $1.96
  • Resistance Level
  • SNGX $2.39
  • MRIN $2.48
  • Average True Range (ATR)
  • SNGX 0.17
  • MRIN 0.14
  • MACD
  • SNGX 0.01
  • MRIN 0.00
  • Stochastic Oscillator
  • SNGX 22.12
  • MRIN 25.06

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About MRIN Marin Software Incorporated

Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.

Share on Social Networks: